ABIVAX Société Anonyme reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 0.1 million compared to EUR 9.7 million a year ago. Net loss was EUR 69.8 million compared to EUR 41.4 million a year ago.
Market Closed -
Other stock markets
|
After market 03:58:01 pm | |||
13.12 EUR | -1.94% | 13.12 | 0.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.60% | 907M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- ABVX Stock
- News Abivax
- ABIVAX Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2022